APA (7th ed.) Citation

N, B., F, M., CT, W., B, B., B, H., DC, A., & L, M. (2026). Increased 18F-FDG Avidity on PET/CT During Treatment for Rhabdomyosarcoma Confirmed to Be Mature Rhabdomyoblasts. Journal of pediatric hematology/oncology. https://doi.org/10.1097/MPH.0000000000003239

Chicago Style (17th ed.) Citation

N, Baca, Majlessipour F, Watterson CT, Balzer B, Hakimian B, Allison DC, and Mascarenhas L. "Increased 18F-FDG Avidity on PET/CT During Treatment for Rhabdomyosarcoma Confirmed to Be Mature Rhabdomyoblasts." Journal of Pediatric Hematology/oncology 2026. https://doi.org/10.1097/MPH.0000000000003239.

MLA (9th ed.) Citation

N, Baca, et al. "Increased 18F-FDG Avidity on PET/CT During Treatment for Rhabdomyosarcoma Confirmed to Be Mature Rhabdomyoblasts." Journal of Pediatric Hematology/oncology, 2026, https://doi.org/10.1097/MPH.0000000000003239.